Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
Just took another look at Chewy and there's something interesting happening beneath the surface that most people are probably overlooking right now.
The stock is trading at 0.83x forward sales, which is genuinely cheap compared to where the broader retail sector sits at 1.61x and especially versus the S&P 500 at 5.19x. Even after the recent bounce, CHWY feels discounted. The consensus price target of $29 assumes only modest multiple expansion, not some huge re-rating. This makes sense because while execution is clearly improving, near-term demand dynamics are still pretty mixed.
What caught my attention though is the profitability story. Chewy's margin expansion isn't a one-time fluke. Through the first three quarters of fiscal 2025, adjusted EBITDA margins stayed in the mid-single digits, hovering around 6.2%, 5.9%, and 5.8% respectively. Management narrowed their full-year EBITDA margin guidance to 5.6%-5.7%, which represents roughly 90 basis points of year-over-year improvement. The way they calculate this formula shows a mix of higher-margin revenue streams like sponsored ads and health services, combined with operational discipline and automation. They're also talking about a multi-year path to hit 10% adjusted EBITDA margins, which would be a meaningful inflection point.
But here's the thing: this is a stability story, not a growth explosion. Autoship subscriptions now represent 84% of net sales, up from 80% a year ago, and grew 13.6% year-over-year to $2.61 billion. That subscription base gives them predictability and better unit economics, but the pet industry itself is only growing low-single digits. Pet household formation is basically flat. So you're getting steady, reliable cash flows rather than some exciting growth narrative.
The fourth quarter is probably going to look messy on paper. Management framed it as an investment quarter with elevated promotions and marketing spend, which will compress margins sequentially and delay some of the operating leverage you'd normally expect. Fourth-quarter adjusted earnings guidance of 24-27 cents a share is notably lower than the 32 cents they did in Q3. That's not great optics, even if the longer-term margin trajectory stays intact.
Customer momentum is the wildcard. Active customers hit 21.2 million, up 5% year-over-year, with about 250,000 sequential adds in Q3 and net sales per customer at $595, also up 5%. App engagement is picking up too. The concern is that management's guidance implies Q4 could see a sequential drop of roughly 150,000 customers. If that happens, the market might interpret it as the recent growth being temporary, even though per-customer engagement metrics are still improving.
On the balance sheet side, there's real cushion. They ended Q3 with $675 million in cash, roughly $1.5 billion in total liquidity, and zero debt. Free cash flow in Q3 improved to $175.8 million from $151.8 million a year prior. They're also returning capital with $55 million in buybacks in Q3 and about $305 million remaining under authorization.
The way I see it, the hold thesis stays intact if two things happen: you get clearer evidence that they can add customers without drowning them in promotions, and the adjusted EBITDA margin expansion continues stepping toward that 10% goal. The Q4 investment period might sting near-term results, but if customer engagement and cash generation hold steady, there's a reasonable case to just wait this out rather than chase any momentum.